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Background: Substitution with opioid-agonists (e.g., methadone) has shown to be an effective treatment for
chronic long-term opioid dependency. Survival sex work, very common among injection drug users, has been
associated with poor Opioid Agonist Treatment (OAT) engagement, retention and response. Therefore, this study
was undertaken to determine factors associated with engaging in sex work among long-term opioid dependent
women receiving OAT.
Methods: Data from a randomized controlled trial, the North American Opiate Medication Initiative (NAOMI),
conducted in Vancouver and Montreal (Canada) between 2005-2008, was analyzed. The NAOMI study compared
the effectiveness of oral methadone to injectable diacetylmorphine or injectable hydromorphone, the last two on a
double blind basis, over 12 months. A research team, independent of the clinic services, obtained outcome
evaluations at baseline and follow-up (3, 6, 9, 12, 18 and 24 months).
Results: A total 53.6% of women reported engaging in sex work in at least one of the research visits. At treatment
initiation, women who were younger and had fewer years of education were more likely to be engaged in sex
work. The multivariate logistic generalized estimating equation regression analysis determined that psychological
symptoms, and high illicit heroin and cocaine use correlated with women’s involvement in sex work during the
study period.
Conclusions: After entering OAT, women using injection drugs and engaging in sex work represent a particularly
vulnerable group showing poorer psychological health and a higher use of heroin and cocaine compared to
women not engaging in sex work. These factors must be taken into consideration in the planning and provision of
OAT in order to improve treatment outcomes.
Trial Registration: NCT00175357.
Keywords: Sex work, opioid dependence, substitution treatment
1. Background
Opioid dependence, frequently manifested as heroin
dependence, is a chronic illness that, when untreated,
can result in adverse health consequences such as
blood-borne viral infections, endocarditis and drug over-
doses [1,2]. Illicit opioid use is also associated with
severe psychosocial problems such as homelessness,
unemployment, loss of family bonds, and illegal activity
[3]. Survival sex work is very common among street
drug users and has been associated with increased drug
related harms [4-7]. Although data indicate that women
as well as men using drugs engage in sex work, women
who use injection drugs are more likely to be involved
in survival sex work compared to men [4,8,9].
Data suggest that women who are injection drug users
(IDU) and engage in sex work present greater vulner-
abilities compared to non-sex workers using injection
drugs. For example, they are more likely to have
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[4,10-12] and fewer years of education [12]. These
women are also more likely to report daily injection her-
oin use [10], higher rates of cocaine use [4] and binge
drug use [13]. These observations suggest that women
who use injection drugs and engage in sex work may be
more vulnerable to adverse physical and psychological
consequences of injection drug use.
Chronic health conditions and infectious diseases,
such as human immunodeficiency virus (HIV) infection
[14,15], hepatitis C [16] and sexually transmitted infec-
tions (STI) are highly prevalent among female sex work-
ers using injection drugs. This has been supported by
s t u d i e ss h o w i n gt h a tH I Vr i s k behaviours, including
sharing injection equipment [4,10,11,17] and inconsis-
tent condom use with clients [10,17] are common risk
behaviours. Moreover, a recent study found that enga-
ging in risky injection practices (e.g., sharing injection
equipment) was more likely among female sex workers
with psychological distress [17], indicating an association
between psychological health and disease risk. Psycholo-
gical health has previously been measured among sex
workers and non-sex workers accessing opioid agonist
therapy (OAT). In a sample of injection drug using
women accessing MMT [12], it was determined that sex
workers had greater psychological symptoms including
depression, anxiety, psychosis and hostility, compared to
women not involved in sex work.
OAT (for example with methadone or buprenorphine) is
widely considered the most effective intervention for
opioid dependency [18]. OAT has been proven effective at
reducing illicit drug use and illegal activities, HIV infec-
tions, as well as improving general health and psychosocial
adjustment [2,18-20]. There is evidence showing that
involvement in sex work may be negatively associated with
OAT access and outcomes, including reduced access to
care [4,21,22] and early withdrawal from a low-threshold
program [23]. Moreover, a recent randomized clinical trial
(RCT) comparing Heroin Assisted Treatment (HAT) to
Methadone Maintenance Treatment (MMT) found female
sex workers had higher illicit drug use and poorer health
outcomes after 12 months of treatment relative to those
not engaged in sex work [8].
The studies described above suggest that among
women using injection drugs, sex work is a factor that
may deter women from being engaged, retained and
responding to OAT. However, the factors that are asso-
ciated with engaging in sex work after entering treat-
ment are not well understood. The present study aims
to determine if health (physical, mental, social), illicit
drug use and treatment retention were associated with
engaging in sex work after initiating OAT in a cohort of
long-term opioid injection drug users.
2. Methods
Design, Setting and Participants
The North American Opiate Medication Initiative
(NAOMI) was an open-label, phase III RCT comparing
supervised injected diacetylmorphine (the active ingredi-
ent in heroin) and oral methadone in the treatment of
long-term opioid dependence. Participants’ profile, study
design, methodology and results of the parent study have
been published elsewhere [24-26]. Briefly, eligible partici-
pants were at least 25 years of age, with a minimum of 5
years of opioid dependence, current daily injection of
opioids, at least two prior treatment attempts for opioid
dependence (including at least one OAT), and no enrol-
ment in OAT within the prior 6 months.
A total of 251 individuals were randomized to receive
oral methadone (n = 111) or injectable opioids (on a
double blind basis: diacetylmorphine, n = 115; hydro-
morphone, n = 25). Oral methadone was dispensed daily
and injectable medications were administered up to
three times daily under the supervision of nursing staff.
Participants were also offered psychosocial services and
primary care on site and all services were delivered in a
patient-centred fashion [27]. Medications were provided
for 12 months. Since injectable medications were not
licensed for addiction treatment, an additional 3-month
period was provided to taper and transition those in the
injection group to other treatment modalities (primarily
methadone). All participants provided written informed
consent and the study was approved by the University
of British Columbia/Providence Health Care and Centre
de Recherche du Centre Hospitalier de l’université de
Montréal research ethics boards.
Measures
A research team, independent of the clinic services,
obtained outcome evaluations at baseline and follow-up
( 3 ,6 ,9 ,1 2 ,1 8a n d2 4m o n t h s ) ,u s i n gt h eE u r o p e a n
Addiction Severity Index ([EuropASI]; [28]), the Mauds-
ley Addiction Profile ([MAP]; [29]) and health related
quality of life instrument- Euroquol ([EQ5D]; [30]). For
the purpose of the present study, participants were con-
sidered retained at each evaluation if they received
addiction treatment on at least 20 of the 30 days in the
month prior to the evaluation.
Information related to sex work was obtained from
the Employment/Support Status questionnaire of the
EuropASI. Participants responded dichotomously to
whether or not they received money from ‘Prostitution’
in the prior 30 days.
Analysis
Continuous variables were described by means, median,
standard deviations and interquartile range, while
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variables. A multivariate logistic regression model esti-
mated by generalized estimating equations (GEE) algo-
rithm for repeated measures was used to determine
factors (socio-demographic, substance use, treatment
history, physical and psychological health, etc.) asso-
ciated with reporting sex work at baseline. To evaluate
the relationship between sex work and study variables
measured during the 12 month treatment period and up
to 24 months follow-up, a bivariate logistic regression
analysis, adjusted by baseline sex trade involvement (i.e.,
a logistic regression model with baseline sex trade invol-
vement and one additional independent variable) was
used. Variables that were determined significant at p
value ≤ 0.1 in bivariate analyses were included in the
adjusted multivariate logistic regression model, esti-
mated by generalized estimating equations (GEE) algo-
rithm for repeated measures. Ethnicity, age, study site,
randomization arm and treatment retention were added
throughout the group variable and final model selec-
tions. Odds ratios (OR) and 95% confidence intervals
(CI) were calculated. Missing observations were consid-
ered as missing in the analysis.
Only four of 154 (1.3%) men reported engaging in sex
work; therefore, analyses were performed for women
only. Of the 97 women entering treatment, we obtained
outcome measures for 81 women at 24 months (83.5%).
3. Results
A total of 52 (53.6%) women receiving oral and inject-
able medications reported being involved in sex work in
at least one of the seven research visits (Table 1). Thir-
teen women who were not engaged in sex work at base-
line reported doing so at some point during the follow-
up period, while 10 of the 52 women were consistently
involved in sex work at each of the seven research visits.
The multivariate analysis of factors associated with base-
line sex work indicated that younger women (OR for
every 5 year increase in age = .76; 95% CI = .57,1.00; p
= .05) and women with less education (OR for each
additional year of education = .81; 95% CI = .66,1.01; p
= .055) were more likely to engage in sex work.
The bivariate logistic regression analysis, adjusted by
baseline sex trade (Table 2), indicated that treatment
retention and health related quality of life were inversely
associated with sex work. Sex work was more likely
among women with poorer scores in social relations,
greater physical and psychological health symptoms and
more days of illicit heroin, cocaine and injection drug
use in the prior month. Women considered to have a
high (≥ 20) or medium (9-19) number of days of injec-
tion drug use in the past 30 days were more likely to
report sex work compared to women with low days (≤
8) of injection. In addition, compared to women who
injected the least amount of times per day (≤ 3), those
with the most frequent daily injection (≥ 7) were more
likely to report sex work in the prior 30 days. There was
a suggestion that injectable treatment had a protective
effect on engagement in sex work with an adjusted odds
ratio of .83. However, this was not statistically signifi-
cant. With only about 45 women in each arm of
NAOMI, the power to detect an odds ratio of .8 is vir-
tually non-existent.
In the multivariate logistic regression GEE model
(Table 3), women with more days of heroin (OR = 1.26;
95% CI = 1.05, 1.15; p = .01) and cocaine use (OR =
1.36; 95% CI = 1.16, 1.60; p < .001) and greater psycho-
logical symptoms (OR = 1.07; 95% CI = 1.03, 1.11; p <
.001) in the prior month were more likely to engage in
sex work compared to those with less psychological
symptoms, and days of heroin and cocaine use.
4. Discussion
The aim of this study was to determine factors asso-
ciated with engaging in sex work among long-term
opioid injection drug users receiving OAT in the frame
of a clinical trial. A higher proportion of women (53.6%)
compared to men (1.3%), reported engaging in sex work
Table 1 Total number of women reporting sex trade
Women Total N = 97
Sex trade n with sex trade % (out of total N) Total N with visit % (out of those with visit)
Ever (a) 52 53.6 97 53.6
Baseline 42 43.3 97 43.3
3 months 28 28.9 89 31.5
6 months 21 21.6 86 24.4
9 months 23 23.7 88 26.1
12 months 23 23.7 92 25.0
18 months 18 18.6 87 20.7
24 months 17 17.5 81 21.0
(a) Reported ever being involved in sex trade at some point during the evaluation period
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to 24 months. At treatment entry, age and education
were associated with sex work, while during the study
period, psychological symptoms and frequent heroin
and cocaine use in the prior 30 days were associated
with sex work.
At treatment initiation, women who were younger and
had fewer years of education were more likely to be
engaged in sex work, factors which have previously been
associated with sex work among women using injection
drugs [4,10,12]. Housing, ethnicity and incarcerations
have also been documented in previous studies [4]. The
lack of such associations in the present study reflects
the homogeneity of the NAOMI sample, possibly due to
study inclusion criteria.
When examining factors associated with sex work
involvement during the study period, women with
poorer treatment outcomes were more likely to engage
in sex work. Specifically, lower treatment retention,
poorer scores in social relations and health related
quality of life, more days of illicit drug use, injection
drug use, and more frequent daily injection in the
prior 30 days. These findings indicate that sex work
was more likely among a subgroup of women who did
n o tf u l l yb e n e f i tf r o mO A T ,an o t e w o r t h yf i n d i n gc o n -
sidering that OAT has shown to reduce many of the
harms associated with long-term heroin use [2,18].
Moreover, in the present study women who were
retained successfully in OAT were less likely to be
involved in sex work and therefore experienced a
reduced vulnerability to harms caused by injection
drug use. While this is not a causal association, it indi-
cates that those involved in sex work were more likely
to drop-out of treatment.
In the multivariate model, psychological symptoms
and high illicit heroin and cocaine use in the prior 30
days were associated with sex work. Similarly, previous
studies have found that sex workers accessing MMT
[12] and syringe exchange programs [10] presented with
higher psychological distress compared to women not
engaged in sex work. In addition, a higher use of sub-
stances [13], including more frequent daily heroin and
cocaine use [4,10] has also been reported among injec-
tion drug using women who also engage in sex work.
T h er e s u l t so ft h ep r e s e n ts t u d yc o m p l e m e n tp r i o r
research in the context of a prospective design that
allowed us to capture predictors of sex work involve-
ment over a 24 month study period. After engaging
these participants in OAT, women who continued enga-
g i n gi ns e xw o r kw e r em o r el i k e l yt oc o n t i n u eu s i n g
heroin and cocaine, independent of OAT retention.
Thus, many women continued engaging in survival sex
work and using illicit heroin, despite that OAT improves
retention and reduces illicit heroin use. The complexity
Table 2 Univariate logistic regression analysis, adjusted
by baseline sex trade, of variables associated with
engaging in sex trade after baseline
Variable (a) OR p-value
(95% CI)
Treatment Retention: (b) 0.41 0.001
Yes vs. No (0.24, 0.68)
Social Relations: (c) 1.08 0.009
Every 0.2 unit increase (1.02, 1.14)
Days injecting drugs: (c) 6.40 < 0.001
High (≥ 20) vs. Low (≤ 8) (3.37,12.18)
3.26 0.002
Medium (9-19) vs. Low (≤ 8) (1.53, 6.95)
Times injecting on a typical day: (d) 5.40 0.001
High (≥ 7) vs. Low (≤ 3) (2.05, 14.22)
Days with heroin use: 5.12 < 0.001
Every 5 day increase (2.76, 9.52)
Days with cocaine use: 5.92 < 0.001
Every 5 day increase (2.77, 12.66)
EQ5D: (e) 0.99 0.019
Every 0.1 unit increase (0.98, 1.00)
Physical health symptoms: (d) 1.05 0.02
Every 1 unit increase (1.01, 1.09)
Psychological symptoms: (d) 1.09 < 0.001
Every 1 unit increase (1.06, 1.13)
OR: Odds ratios; CI: Confidence Interval
(a) All variables refer to the prior month;
(b) Retention to treatment: at least 20 out of prior 30 days;
(c) EuropASI (European version of the Addiction Severity Index). Sub-scale
scores range from 0 to 1; higher scores are indicative of more severe
problems;
(d) MAP (Maudsley Addiction Profile). Scores range from 0 to 40; higher scores
are indicative of more symptoms;
(e) EQ5D (Euroquol) Scores range from 0 to 1; higher scores are indicative of
less severe problems; EQ5D index score with U.S. weights.
Table 3 Multivariate GEE model of predictors of
engaging in sex trade after baseline
Variable (a) OR p-value
(95% CI)
Heroin use: 1.26 0.01
Every 5 day increase (1.05, 1.15)
Cocaine use: 1.36 < 0.001
Every 5 day increase (1.16, 1.60)
Psychological symptoms: (b) 1.07 < 0.001
Every 1 unit increase (1.03, 1.11)
OR: Odds ratios; CI: Confidence Interval;
Model adjusted by ethnicity, interaction between age and randomization arm,
treatment retention (not significant) and study site and baseline sex work
(significant).
(a) All variables refer to the prior month;
(b) MAP (Maudsley Addiction Profile). Scores range from 0 to 40; higher scores
are indicative of more symptoms.
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impact on sex work engagement requires further study.
Education is regarded as a strong indicator of social
and health-related inequalities [31], and women with
fewer years of education were more likely to engage in
sex work at treatment initiation. These findings indicate
that women with less education experience further vul-
nerabilities even within a population with very low
socio-economic status. Therefore, those who provide
addiction treatment services must consider this special
circumstance, acknowledging women’s financial needs
and the stigma attached to sex work, so that services
and policies do not further exclude these groups.
The present study focuses on long-term opioid injec-
tion drug using women with and without involvement
in sex work. It is well known that opioid-dependent
individuals often show poor mental and physical health
as well as poor psychosocial functioning, especially after
long-term use [3,32,33]. There is also growing research
evidence among women and men accessing OAT
demonstrating that women enter treatment with worse
physical and psychological health [8,9], as well as higher
opioid and stimulant use [34,35,35]. Some evidence has
also suggested that women have poorer OAT outcomes
compared to men [8,9]. Therefore, women using injec-
tion drugs represent a particularly important group in
the provision of effective addiction treatment.
Unexpectedly, there was no association between victi-
mization (e.g., physical, emotional, and sexual abuse)
and sex work in the present study. Previous studies have
shown high rates of physical and sexual abuse in sex
workers’ childhood, and later victimization by partners
[12,36] and clients in adulthood [37]. Moreover, in a
cohort study of youth using substances, childhood sex-
ual abuse was independently associated with sex work
[38]. One possible explanation for the absence of this
expected association may be related to the measure of
victimization. The Addiction Severity Index (ASI) has
been used to evaluate abuse in several studies [39], mea-
suring victimization with a general question (e.g., “have
you ever been physically or sexually abused?”). There-
fore, [40-42] details regarding the nature of the event,
which might account for the associations between victi-
mization and sex work, are undetermined [43,44].
Limitations of the NAOMI study have been discussed
elsewhere [24,25]. It should be noted that the analysis
were intent-to-treat, therefore, some of the higher inten-
sity drug use occurred in participants who were not
receiving the treatments as provided in the study (oral
and injectable arms). Several gender sensitive and sex
work specific-related questions were not part of the
study evaluation package (e.g., partner’s use of illicit
substances, income earned from sex work to support
heroin use), that data would have provided a more
detailed picture of the situation. In addition, the trial
was not designed to investigate factors associated with
sex work and we had a small sample size; however it
provided an opportunity to obtain valuable information
on this topic in the context of women receiving OAT.
I no r d e rt ob e t t e rc o n c e p t u a l i z et h er e l a t i o n s h i p
between high intensity drug use and sex work, addi-
tional data regarding the reasons for sex work involve-
ment during treatment, the proportion of earnings used
from sex work to support illicit drug use, and informa-
tion regarding the people whod e p e n do na ni n d i v i d u a l
involved in sex work, should be captured..
The findings presented suggest that participation in
NAOMI positively affected the pattern of sex work,
showing a decline from enrolment to 24 months fol-
low-up. At treatment entry, all NAOMI participants
had not received any treatment for the six months
prior to study enrolment (as per inclusion criteria);
therefore considered un-treated despite the available
options (e.g., methadone treatment). Engagement in
treatment was associated with a decline in sex work
over time. This particular group would have likely
remained outside of addiction treatment services, and
likely only initiated treatment for the opportunity to
receive injectable diacetylmorphine. Certainly,
approaches that improve treatment engagement (such
as medically prescribed diacetylmorphine) for long-
term treatment refractory heroin injectors, must be
supported by current policies.
5. Conclusion
Findings of this study suggest that injection drug using
women engaged in sex work represent a highly vulner-
able group with poorer psychological health and a
greater use of heroin and cocaine while receiving OAT.
Future research should aim to better understand the cir-
cumstances around illicit drug use and sex work among
opioid-dependent individuals’ receiving OAT, as these
activities impact treatment outcomes and the addiction
recovery process. In addition, mixed methods studies
exploring sex workers’ perceptions of OAT and barriers
to treatment engagement may provide valuable informa-
tion for the development of future interventions and
design of tailored services which should aim to simulta-
neously reduce the harms associated with injection drug
use and sex work.
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